EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases

EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases

Autor tenBerge, J. Google Scholar
Hoffman, B. J. Google Scholar
Hawes, R. H. Google Scholar
van Enckevort, C. Google Scholar
Giovannini, M. Google Scholar
Erickson, R. A. Google Scholar
Catalano, M. F. Google Scholar
Fogel, R. Google Scholar
Mallery, S. Google Scholar
Faigel, D. O. Google Scholar
Ferrari, A. P. Google Scholar
Waxman, I Google Scholar
Palazzo, L. Google Scholar
Ben-Menachem, T. Google Scholar
Jowell, P. S. Google Scholar
McGrath, K. M. Google Scholar
Kowalski, T. E. Google Scholar
Nguyen, C. C. Google Scholar
Wassef, W. Y. Google Scholar
Yamao, K. Google Scholar
Chak, A. Google Scholar
Greenwald, B. D. Google Scholar
Woodward, T. A. Google Scholar
Vilmann, P. Google Scholar
Sabbagh, L. Google Scholar
Wallace, M. B. Google Scholar
Instituição Med Univ S Carolina
Inst J Paoli I Calmettes
Scott & White Mem Hosp & Clin
GI Consultants Ltd
Clin Caracas
Hennepin Cty Med Ctr
Portland Vet Adm Hosp
Universidade Federal de São Paulo (UNIFESP)
Univ Chicago
Univ Paris 07
Henry Ford Hosp
Duke Univ
Thomas Jefferson Univ Hosp
Mayo Clin
Univ Massachusetts
Aichi Canc Ctr Hosp
Univ Hosp Cleveland
Univ Maryland
Gentofte Univ Hosp
Clin Reina Sofia
Resumo Background.-The liver is a common site of metastases for various malignancies. EUS-guided fine needle aspiration (EUS-FNA) of liver masses has only been reported in small series from single centers. Methods: A retrospective questionnaire was sent by e-mail to 130 EUS-FNA centers around the world regarding indications, complications, and findings of EUS-FNA of the liver.Results: Twenty-one centers reported 167 cases of EUS-FNA of the liver. A complication was reported in 6 (4%) of 167 cases including the following: death in 1 patient with an occluding biliary stent and biliary sepsis, bleeding (1), fever (2), and pain (2). EUS-FNA diagnosed malignancy in 23 of 26 (89%) cases after nondiagnostic fine needle aspiration under transabdominal US guidance. EUS localized an unrecognized primary tumor in 17 of 33 (52%) cases in which CT had demonstrated only liver metastases. EUS image characteristics were not predictive of malignant versus benign lesions.Conclusion: EUS-guided FNA of the liver appears to be a safe procedure with a major complication rate of approximately 1%. EUS-FNA should be considered when a liver lesion is poorly accessible to US-, or CT-guided FNA should be considered when US- or CT-guided FNA fail to make a diagnosis, when a liver lesion(s) is detected (de novo) by EUS, and for investigation of possible upper GI primary tumors in the setting of liver metastases.
Idioma Inglês
Data de publicação 2002-06-01
Publicado em Gastrointestinal Endoscopy. St Louis: Mosby, Inc, v. 55, n. 7, p. 859-862, 2002.
ISSN 0016-5107 (Sherpa/Romeo, fator de impacto)
Publicador Mosby, Inc
Extensão 859-862
Fonte http://dx.doi.org/10.1067/mge.2002.124557
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000175990300016
Endereço permanente http://repositorio.unifesp.br/handle/11600/26890

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta